Although no COVID-19 vaccine is ready for distribution yet, dentists in Oregon are prepared to administer it and other necessary vaccinations to their patients. In May 2019, Oregon became the first state to allow dentists to prescribe and…

Results of a study that looked at more than 21,000 COVID-19 exposures among Minnesota healthcare workers showed that 25% were high-risk exposures in which the healthcare provider was within 6 feet of an infected patient for more than 15…

An ongoing trial of the antibody bamlanivimab—administered with remdesivir, an antiviral medication—on hospitalized COVID-19 patients has been halted by bamlanivimab’s manufacturer Eli Lilly. The decision was made to stop the trial after…

Even though they are at high risk of complications related to COVID-19, older adults are happier than younger people as the global pandemic continues on. The study, based out of Stanford University in Stanford, California, included 1,000…

Phase 3 General Distribution Funding from the United States Department of Health and Human Services Provider Relief Fund is available to dental practices. Opening on October 5 and closing November 6, the funding is part of the Coronavirus…

Two peer-reviewed studies demonstrate a decrease in deaths among hospitalized patients with COVID-19 across the board, including older adults and those with comorbidities. One study looked at 5,000 hospitalized COVID-19 patients in New York…

A University of Michigan School of Dentistry survey found that oral health professionals are less afraid of COVID-19 than other healthcare providers and non-healthcare providers, even though their work is noted as high risk. The survey of…

A survey of European experts in oral and maxillofacial surgery found that 80% noted aerosol-generating procedures in the dental setting as high risk in the transmission of the novel coronavirus. More than 80% asserted that face protection…

The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (brand name Veklury, Gilead Sciences) for treating patients hospitalized with COVID-19. This is the first treatment for COVID-19 to receive FDA approval.…

The United States Centers for Disease Control and Prevention (CDC) changed the definition of “close contact,” from spending 15 minutes consecutively within 6 feet of a person infected with the novel coronavirus to a total of 15…